Ask AI
ProCE Banner Activity

Global Insights, Local Impact: Practical Pathways for Integrating Biomarkers in Alzheimer’s Care

Slideset

This downloadable slideset, developed by international Alzheimer’s disease experts, describes potential utilization of blood-based biomarkers in clinical care, facilitating the early detection and diagnosis of Alzheimer’s disease.

Released: June 23, 2026

Share

Provided by

Provided by Clinical Care Options, LLC dba Decera Clinical Education

ProCE Banner

Supporters

This activity is supported by an educational grant from Lilly.

Lilly

Target Audience

This activity is intended for global primary care physicians, general practitioners, general neurologists, nurse practitioners, physician associates, and other healthcare professionals caring for patients at risk of developing Alzheimer’s Disease.

Learning Objectives

Upon completion of this activity, participants should be able to:

  • Evaluate emerging evidence on the clinical utility of blood-based biomarkers to enhance timely and accurate diagnosis of AD

  • Identify appropriate patients for blood-based biomarker testing to support individualized care pathways

  • Apply evidence-based strategies and clinical guidance on biomarker testing to direct clinical decision-making and referrals across the AD care continuum